EUR 21.7
(-0.46%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -720 Thousand EUR | 94.26% |
2022 | -12.54 Million EUR | -523.53% |
2021 | 2.96 Million EUR | 12778.26% |
2020 | 23 Thousand EUR | -99.78% |
2019 | 10.26 Million EUR | 0.97% |
2018 | 10.16 Million EUR | -5.8% |
2017 | 10.79 Million EUR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 Q1 | -22.29 Million EUR | -77.72% |
2023 FY | -720 Thousand EUR | 94.26% |
2023 Q3 | -1.72 Million EUR | 93.0% |
2023 Q2 | -24.58 Million EUR | -10.26% |
2023 Q4 | -720 Thousand EUR | 58.14% |
2022 Q3 | -9.54 Million EUR | -1693.49% |
2022 FY | -12.54 Million EUR | -523.53% |
2022 Q2 | 599 Thousand EUR | -84.87% |
2022 Q1 | 3.95 Million EUR | 33.66% |
2022 Q4 | -12.54 Million EUR | -31.43% |
2021 FY | 2.96 Million EUR | 12778.26% |
2021 Q4 | 2.96 Million EUR | -56.89% |
2021 Q3 | 6.87 Million EUR | 171.15% |
2021 Q2 | -9.65 Million EUR | -90.62% |
2021 Q1 | -5.06 Million EUR | -22121.74% |
2020 Q1 | 74.52 Million EUR | 676.72% |
2020 FY | 23 Thousand EUR | -99.78% |
2020 Q4 | 23 Thousand EUR | 0.0% |
2019 FY | 10.26 Million EUR | 0.97% |
2019 Q4 | 9.59 Million EUR | 0.0% |
2018 FY | 10.16 Million EUR | -5.8% |
2017 FY | 10.79 Million EUR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
ARTERRA BIOSCIENCE | -2.73 Million EUR | 73.655% |
Ulisse Biomed S.p.A. | -2.29 Million EUR | 68.574% |